Clinical Characteristics of Small Intestinal Bacterial Overgrowth in Individuals with Abdominal Distention

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorShandong University

About this trial

Abdominal distention represents a prevalent clinical manifestation characterized by an unclear etiology and pathogenesis. This symptomatology is frequently observed in various conditions, including small intestinal bacterial overgrowth (SIBO) and abnormal orocecal transit time (OCTT). The utilization of the breath test as a non-invasive diagnostic approach has become widespread in recent years for identifying SIBO and abnormalities in OCTT. In this study, the prevalence of SIBO and OCTT irregularities in individuals presenting with abdominal distention was ascertained through the implementation of the breath test. Furthermore, the correlation between abdominal distention and SIBO/OCTT was analysed to enhance the elucidation of the underlying etiology of abdominal distention. These findings aim to offer valuable insights for refining clinical comprehension and strategies related to the diagnosis and treatment of abdominal distention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18 to 70 years.

Patients presenting with the primary complaint of abdominal bloating and/or abdominal distension, or those exhibiting abdominal distension with prominence over other symptoms.

Disqualifiers

Patients who are pregnant or lactating.

Patients have history of gastrointestinal malignancy or gastrointestinal surgery.

Patients manifesting food intolerance or presenting with a confirmed diagnosis or suspicion of lactose intolerance.

Patients with urinary system (chronic kidney disease, etc.), immune system (scleroderma, etc.), nervous system (Parkinson's disease, etc.), mental system (depression, etc.), or other diseases outside the digestive system.

Trial population

Abdominal distension patients in the outpatient department at Qilu Hospital of Shandong University.

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

  • Breath test

    Diagnostic test

    The concentration of methane and hydrogen in the exhaled gas of patients with Abdominal distention is measured by a breath test to determine the presence of SIBO and abnormal OCTT.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Positive rate of SIBO in patients with abdominal distension

Detect the positive rate of SIBO in patients with abdominal distension by breath test

Time frame
2024-03-01 to 2025-08-01

Secondary outcomes

1

Positive rate of abnormal OCTT in patients with abdominal distension

Detect the positive rate of abnormal OCTT in patients with abdominal distension by breath test

Time frame
2024-03-01 to 2025-08-01
2

Correlation between clinical features of patients with abdominal distension and SIBO

Analyze the correlation between clinical features of patients with abdominal distension and SIBO

Time frame
2024-03-01 to 2025-08-01
3

Correlation between clinical features of patients with abdominal distension and OCTT

Analyze the correlation between clinical features of patients with abdominal distension and OCTT

Time frame
2024-03-01 to 2025-08-01

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Shandong University

Lead sponsor

Qilu Hospital of Shandong University (Qingdao)

Collaborator

Jinan Central Hospital

Collaborator

Zaozhuang Municipal Hospital

Collaborator

Weihai Municipal Hospital

Collaborator

Central Hospital of Zibo

Collaborator

Weifang People's Hospital

Collaborator

Dezhou Hospital Qilu Hospital of Shandong University

Collaborator

Binzhou Medical University

Collaborator

Qihe Xian Renmin Hospital

Collaborator